Synonyms: MK7622
Compound class:
Synthetic organic
Comment: MK-7622 is a high cooperativity positive allosteric modulator of the M1 muscarinic acetylcholine receptor (M1R) [1-3]. Clinical development of MK-7622 as a therapy for neurological and cognitive disorders was terminated at Phase 2.
|
|
No information available. |
Summary of Clinical Use ![]() |
MK‐7622 was advanced to clinical trial in patients with Alzheimer's disease to evaluate its potential to improve memory deficit [4]. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT01852110 | Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) | Phase 2 Interventional | Merck Sharp & Dohme Corp. | MK-7622 had no effect on cognition as an adjunct to acetylcholinesterase inhibitor therapy in this proof-of-concept study. | 4 |